A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors
Clinical trial NCT05718895 · RECRUITING
Trial details
- NCT number
- NCT05718895
- Sponsor
- Antengene Biologics Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2027-12-30
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.